Repligen Corporation

Repligen Corporation (Repligen) is a biopharmaceutical company focused on the development of novel therapeutics primarily for the treatment of diseases of the central nervous system. Repligen is developing novel therapeutics primarily for radiology and neuropsychiatry. A number of drug development programs are being conducted to evaluate the Company's drug candidates in diseases, such as pancreatitis, bipolar disorder and neurodegeneration. In addition, Repligen sells a line of products based on Protein A for monoclonal antibody purification. (Source: 10-K)


There are no scholarships at this time


There are no events at this time

Company Data on Repligen Corporation
provided by Owler


Repligen Corporation is hiring for these positions

Show me: All available jobs